echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The team of Fan Dongsheng from Peking University Third Hospital was invited to comment on the global research progress of amyotrophic lateral sclerosis in The Lancet Neurology

    The team of Fan Dongsheng from Peking University Third Hospital was invited to comment on the global research progress of amyotrophic lateral sclerosis in The Lancet Neurology

    • Last Update: 2022-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 22, 2022, Lancet Neurology ("The Lancet Neurology"), a sub-journal of Lancet, published a specially invited review article Amyotrophic lateral sclerosis: new era, new challenges ( Amyotrophic Lateral Sclerosis: New Era, New Challenges)




    Amyotrophic lateral sclerosis is one of the first neurodegenerative diseases to be included in the list of rare diseases in China.



    Professor Fan Dongsheng's team has been engaged in basic and clinical research on amyotrophic lateral sclerosis for a long time, and has done a lot of original work in many fields such as pathogenesis, electrophysiological diagnostic methods, natural history of the disease, and clinical trials, and the research results have reached the international advanced level.



    Original link: https://doi.




    (Tang Lu and Wang Xueying, Peking University Third Hospital)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.